64x Bio’s Post

#Interview now available! Exploring the convergence of #geneediting and #RNAi in iPSC-derived #allogeneic cell therapy Within cell and #genetherapy, there is a growing reliance on innovation in #genomeediting technology. Read this interview with Vlad Seitan, (Chief Scientific Officer, Laverock Therapeutics) about enhancing advanced therapies through a novel approach that combines the power of gene editing with the #RNAinterference (RNAi) pathway. Read below:

Once more, BD is at the forefront when it comes to improving cell and gene therapy manufacturing processes. When it comes to CAR-T cells characterization, our expertise really makes the difference! #CellTherapy #GeneTherapy #ATMPs #AdvancedTherapies #Tcells #BD #bectondickinson #flowcytometry #proudtobeBD

Cell and gene therapies are revolutionizing healthcare, yet scaling production remains challenging. As you work to streamline processes and drive down costs, key questions arise: • How do you minimize process variability? • Can you seamlessly transition from research to production? • What's the best approach to scaling up manufacturing? We are committed to addressing these challenges head-on with advanced technologies and tailored services to empower you to accelerate development and standardize processes. Learn how to streamline your workflow below! #Biotechnology #HealthcareInnovation #CellTherapy #GeneTherapy #BioTechne #FutureOfHealthcare

#Article now available! Early-stage considerations for accelerating cell and #genetherapy commercialization The cell and gene therapy field continues to advance at an unprecedented pace. In keeping up with the complex process development landscape and changing regulatory requirements, emerging #biotechs and early-stage organizations, including academia and research institutions, face unique challenges. This article will provide the essential knowledge and practical insights needed to accelerate the development of safe and effective cell and gene therapies.

A great example of partnership driving acceleration of cell and gene therapy manufacturing processes. #CellTherapy #GeneTherapy #ATMPs #AdvancedTherapies #Tcells #BD #bectondickinson #flowcytometry #proudtobeBD

A great example of a complex 12 color panel on the BD FACSLyric to identify T cell phenotypes #CellTherapy #ATMPs #AdvancedTherapies #Tcells #BD #bectondickinson #flowcytometry 

It is truly brilliant to see how the BD FACSLyric™ Flow Cytometer has been used to help improve cell and gene therapy manufacturing processes. Also, this is a fantastic example of a complex 12 color panel on the BD FACSLyric™ Flow Cytometer. #CellTherapy #GeneTherapy #ATMPs #AdvancedTherapies #Tcells #BD #bectondickinson #flowcytometry #proudtobeBD

Proud that BD were able to provide the expertise to support the development of a complex 12 colour panel used for the characterisation of CAR-T cells during the optimisation of a bioprocess. #CellTherapy #GeneTherapy #ATMPs #AdvancedTherapies #Tcells #BD #bectondickinson #flowcytometry

Are you ready to advance your #CRISPRsolutions? Visit IDT at the Cell & Gene Therapy Research & Development Congress Asia, booth #2, to explore CRISPR solutions with IDT experts. Also, don't miss our #CRISPR experts’ presentation, "Innovative strategies in T-cell engineering: Leveraging IDT’s #CRISPRtechnology for personalized therapeutics." See you there! #genetherapy

CRISPR Alternative ✨ Have you heard about Applied StemCell's TARGATT site-specific knock-in technology? Our TARGATT system facilitates single copy insertion of large DNA fragments at a preselected safe harbor locus in iPSCs, HEK293 cells, and CHO cells. - Site-specific knock-in at a preselected safe harbor locus (no random integration) - Single-copy gene insertion - Large transgene knock-in (up to 20 kb) - Uninform expression - High integration efficiency & high-level expression of the transgene With TARGATT, you can avoid the limitations of standard gene editing technologies and create stable, high-expression engineered cells for your research. Start by exploring ASC's TARGATT technology today. It may be what you need to expand your research! Learn more @ https://lnkd.in/dxWDcEC Or contact us at [email protected] We also invite you to visit our new TARGATT technology page: 🔗 https://lnkd.in/gdGSnQ2z #TARGATT #geneediting #iPSCs #cellandgenetherapy